Epigenetic approaches and methods in developmental toxicology: Role of HDAC inhibition in teratogenic events

Methods in Molecular Biology

Volumn 889, Issue , 2012, Pages 373-383

  Menegola, Elena ^a   Cappelletti, Graziella ^a   Di Renzo, Francesca ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Embryo; Embryonic nuclear extract preparation; Enzymatic activity assay; HDAC; HDACi; Immunohistochemistry; Malformation; Teratogenesis; Valproic acid; Western blot

Indexed keywords

HISTONE DEACETYLASE; VALPROIC ACID; XENOBIOTIC AGENT; HISTONE; HISTONE DEACETYLASE INHIBITOR; TERATOGENIC AGENT; TISSUE EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; DEVELOPMENTAL TOXICITY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME INHIBITION; EPIGENETICS; GAMETOGENESIS; HISTONE ACETYLATION; IMMUNOHISTOCHEMISTRY; MOUSE EMBRYO; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; TERATOGENESIS; WESTERN BLOTTING; ZYGOTE; ACETYLATION; ANIMAL; ANIMAL EMBRYO; CHEMISTRY; DRUG EFFECT; FEMALE; GENETIC EPIGENESIS; HELA CELL; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROTOMY; MOUSE; PREGNANCY; TISSUE FIXATION; TOXICITY TESTING;

ACETYLATION; ANIMALS; BLOTTING, WESTERN; EMBRYO, MAMMALIAN; EPIGENESIS, GENETIC; FEMALE; HELA CELLS; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; MICE; MICROTOMY; PREGNANCY; RATS; TERATOGENS; TISSUE EXTRACTS; TISSUE FIXATION; TOXICITY TESTS; VALPROIC ACID;

EID: 84866490135     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-867-2_23     Document Type: Article

References (10)

1. Acharya MR, Sparreboom A, Venitz J et al (2005) Rational development of histone deacetylase inhibitors as anticancer agents: a review. Mol Pharmacol 68:917-932
2. Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4:143-153
3. Garcia-Manero G, Issa JP (2005) Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents. Cancer Invest 23:635-642
4. Menegola E, Di Renzo F, Broccia ML, Prudenziati M, Minucci S, Massa V, Giavini E (2005) Inhibition of histone deacetylase activity on speci fic embryonic tissues as a new mechanism for teratogenicity. Birth Defects Res B 74:392-398
5. Menegola E, Di Renzo F, Broccia ML, Giavini E (2006) Inhibition of histone deacetylase as a new mechanism of teratogenesis. Birth Defects Res C 78:345-353
6. Di Renzo F, Cappelletti G, Broccia ML, Giavini E, Menegola E (2007) Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related terato-genicity. Toxicol Appl Pharmacol 220: 178-185
7. Di Renzo F, Broccia ML, Giavini E, Menegola E (2007) Relationship between embryonic histonic hyperacetylation and axial skeletal defects in mouse exposed to the three HDAC inhibitors apicidin, MS-275, and sodium butyrate. Toxicol Sci 98:582-588
8. Di Renzo F, Cappelletti G, Broccia ML, Giavini E, Menegola E (2008) The inhibition of embryonic histone deacetylases as the possible mechanism accounting for axial skeletal malfor-mations induced by sodium salicylate. Toxicol Sci 104:397-404
9. Di Renzo F, Broccia ML, Giavini E, Menegola E (2010) VPA-related axial skeletal defects and apoptosis: a proposed event cascade. Reprod Toxicol 29:106-112
10. Bradford MM (1976) A rapid sensitive method for quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72:248-254